Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

89.79
-0.0400-0.04%
Post-market: 89.790.00000.00%19:52 EDT
Volume:2.82M
Turnover:253.16M
Market Cap:51.77B
PE:52.23
High:90.37
Open:89.89
Low:88.79
Close:89.83
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:1.01
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.88
PE(LYR):48.99

Loading ...

Stock Track | Edwards Lifesciences Soars 5.76% in 24-Hour Trading on Q2 Earnings Beat, Raised Guidance, and Strong Heart-Device Demand

Stock Track
·
Jul 24

American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday

Benzinga Earnings
·
Jul 24

Edwards Lifesciences Corp : JP Morgan Raises Target Price to $105 from $100

THOMSON REUTERS
·
Jul 24

Dow Jones Top Company Headlines at 9 PM ET: Intel Shares Rise as Sales Surge 25% in Second Quarter | HSBC ...

Dow Jones
·
Jul 24

Stocks to Watch: Intel, Deckers, Edwards Lifesciences, Genmab

Dow Jones
·
Jul 24

Edwards Lifesciences Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 24

Edwards Lifesciences Beats Quarterly Estimates on Strong Demand for Heart Devices

Reuters
·
Jul 24

Edwards Lifesciences Narrows Full-year Sales Outlook After 2Q Growth

Dow Jones
·
Jul 24

Edwards Lifesciences Q2 FY26 EPS Drops to $0.42; Net Sales Rise 13.6% to $1.74 Billion

Reuters
·
Jul 24

Stock Track | Edwards Lifesciences Soars 7.37% in After-Hours Trading on Q2 Earnings Beat and Reaffirmed Guidance

Stock Track
·
Jul 24

Edwards Lifesciences Q2 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $1.741B Beat $1.700B Estimate

Benzinga Earnings
·
Jul 24

Edwards Lifesciences Q2 Sales USD 1,741 Million VS. Ibes Estimate USD 1,700 Million

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Corp - Expects 2026 Sales of $6.6-$6.90 Bln

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Outlook Q3 Adjusted EPS USD 0.71-0.77

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Corp - Reaffirms 2026 Adj EPS Guidance of $2.95-$3.05

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Corp Fy2026 Shr View $3.01, REV View $6.75 Bln

THOMSON REUTERS
·
Jul 24

U.S. Earnings Preview: After Market Close July 23

Dow Jones
·
Jul 24

Edwards Lifesciences options imply 6.5% move in share price post-earnings

TIPRANKS
·
Jul 24

Press Release: Visionwave and Meteor Aerospace Leadership Advance Integration Planning for Ai-enabled Multi-domain Defense Technologies Following Previously Announced Acquisition Agreement

Dow Jones
·
Jul 23

Edwards Lifesciences: Buy Rating Reaffirmed as Analyst Lifts Price Target from $85 to $104 on TAVR Momentum and TMTT Catalysts

TIPRANKS
·
Jul 22